| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | NEF ELISA Kit; Protein S100 B ELISA Kit; Protein S100-B ELISA Kit; S 100 calcium binding protein beta chain ELISA Kit; S 100 protein beta chain ELISA Kit; S-100 protein beta chain ELISA Kit; S-100 protein subunit beta ELISA Kit; S100 ELISA Kit; S100 calcium binding protein beta (neural) ELISA Kit; S100 calcium-binding protein B ELISA Kit; S100 protein beta chain ELISA Kit; S100B ELISA Kit; S100B_HUMAN ELISA Kit; S100beta ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates, cerebrospinal fluid (CSF) |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
Soluble protein-100B,S-100B (S100B) is a biological molecule commonly studied in signal transduction research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P04271
Biological context
Researchers often monitor Soluble protein-100B,S-100B in serum, plasma, tissue homogenates, and cerebrospinal fluid (CSF) to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in Soluble protein-100B,S-100B may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, Soluble protein-100B,S-100B may also appear under names such as NEF and Protein S100 B. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Soluble protein-100B,S-100B participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Facial nerve palsy and Lyme neuroborreliosis in children: treatment and outcome
S Árnason,Thesis & Dissertation,2025
Early Effect of Radiotherapy on Serum Levels of HSP70 and S100B in Patients with Breast Cancer
Ö Elif Eda,Turk J Oncol,2023
Biological Markers in Newly Diagnosed Generalized Anxiety Disorder Patients: 8-OHdG S100B and Oxidative Stress
F Zhou,Neuropsychiatric disease and treatment,2024
Incremental Metabolic Benefits from Cryoablation for Paroxysmal Atrial Fibrillation: Insights from Metabolomic Profiling
J Wang,/,2024
Predictive value of soluble CD59 for poor 28-day neurological prognosis and all-cause mortality in patients after cardiopulmonary resuscitation: a prospective observatory study
L Wang,Journal of intensive care,2023
Higher serum PGE2 is a predicative biomarker for postoperative delirium following elective orthopedic surgery in elderly patients
M Mao,BMC geriatrics,2022
Evaluation of Preoperative and Postoperative S100β and NSE Levels in Liver Transplantation and Right Lobe Living-Donor Hepatectomy: A Prospective Cohort Study
B Dinc,Transplantation Proceedings,2020
Neuronal Biomarkers in Predicting Neurodevelopmental Outcome in Term Babies with Perinatal Asphyxia
RC Catherine,The Indian Journal of Pediatrics,2020
Associations of serum S100B and S100P with the presence and classification of diabetic peripheral neuropathy in adults with type 2 diabetes: a case-cohort study
MohsenAfarideh, et al,Canadian Journal of Diabetes,2019
S100B as a biomarker for differential diagnosis of intracerebral hemorrhage and ischemic stroke.
Zhou S.et al,Neurol Res.,2016
Tethered cord syndrome - a study of the short term effects of surgical detethering onMarkers of neuronal injury and electrophysiologic parameters
Maurya VP.et al,World Neurosurg.,2016
Estetrol attenuates Neonatal Hypoxic-Ischemic brain injury Running title: Estetrol and its neuroprotective effect
Ekaterine Tskitishvili. et al,researchgate,2014
Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients
/,Thesis,2011